A cluster randomised controlled trial of the effectiveness and cost effectiveness of statin facilitation in primary care
| ISRCTN | ISRCTN61233866 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN61233866 |
| Protocol serial number | 03PH02 |
| Sponsor | Greater Glasgow Primary Care NHS Trust (UK) |
| Funder | Greater Glasgow NHS Primary Care Division |
- Submission date
- 15/06/2006
- Registration date
- 06/07/2006
- Last edited
- 25/01/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Richard Lowrie
Scientific
Scientific
Primary Care Research and Development Directorate
Gartnavel Royal Hospital
1055 Great Western Road
Glasgow
Scotland
G12 OXH
United Kingdom
| Phone | +44 (0)141 211 3690 |
|---|---|
| Richard.lowrie@gartnavel.glacomen.scot.nhs.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | A cluster randomised controlled trial of the effectiveness and cost effectiveness of statin facilitation in primary care |
| Study objectives | An intervention involving pharmacists providing a new form of outreach visit to general practitioners and practice nurses is effective and cost effective. |
| Ethics approval(s) | December 2002, Greater Glasgow Primary Care Local Research Ethics Committee |
| Health condition(s) or problem(s) studied | Vascular disease |
| Intervention | Three educational outreach visits delivered by pharmacists to general practitioners and practice nurses in study practices, with the aim of improving the prescribing of statins for patients with vascular diseases. Control group receive normal care: annual dissemination of Health Board guideline in paper format. They did not receive pharmacist led prescribing support during the trial. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Simvastatin |
| Primary outcome measure(s) |
The proportion of patients with cholesterol in target range |
| Key secondary outcome measure(s) |
The proportion of patients prescribed an evidence based dose of statin |
| Completion date | 01/07/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target sample size at registration | 30 |
| Key inclusion criteria | Target: 30 general practices in National Health Service (NHS) Glasgow with patients with vascular diseases (where a statin is indicated). |
| Key exclusion criteria | N/A |
| Date of first enrolment | 20/05/2003 |
| Date of final enrolment | 01/07/2006 |
Locations
Countries of recruitment
- United Kingdom
Study participating centre
Primary Care Research and Development Directorate
Scotland
G12 OXH
United Kingdom
G12 OXH
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 18/11/2014 | Yes | No | |
| Protocol article | protocol | 01/07/2010 | Yes | No |
Editorial Notes
25/01/2016: Publication reference added.
